Cancer Treatment using Specified Products     

FOI REFERENCE: 24169   FOI DATE: 13^th June 2024     

1) In the past 6 months, what was the number of patients treated with a combination of Dabrafenib + Trametinib for the following conditions:

A) Metastatic Melanoma 0 patients

B) Adjuvant Melanoma 5 patients

C) BRAF mutated Lung Cancer 0 patients

2) In the past 6 months, what was the number of patients treated with a combination of Encorafenib (Braftovi) + Binimetnib (Mektovi) for the following conditions:

A) Metastatic Melanoma 0 patients

B) Colorectal Cancer 0 patients